By Drew Armstrong, Bloomberg |
November 1, 2012
Pfizer Inc., the world’s biggest drugmaker, narrowed its 2012 forecast after reporting third- quarter earnings that met analyst estimates and sales that fell short of expectations.
Crude stubbornly drills toward record
Bitreserve raises nearly $10 million; Coinbase funding global expansion
Option check: Russian stocks rebound
NIBA makes NFA endorsements
Simplifying fibonacci for traders
Lower crude produces winners & losers...